Thermo Fisher Scientific Selected to Support National Institute of Health’s Blueprint MedTech program

Tuesday, February 21, 2023
NIH Default Logo

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, has been awarded a five-year contract to provide regulatory affairs support and related services for the Blueprint MedTech (BPMT) program, a new multi-institute/center initiative at the National Institutes of Health (NIH) supporting development of translational neurological devices.

Read Full Article